BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8232234)

  • 1. A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors.
    Redman RS; Silinsky EM
    Mol Pharmacol; 1993 Oct; 44(4):835-40. PubMed ID: 8232234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors.
    Giniatullin RA; Sokolova EM
    Br J Pharmacol; 1998 Jun; 124(4):839-44. PubMed ID: 9690879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P1-purinoceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicin-sensitive nonadrenergic noncholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype.
    Rubino A; Ralevic V; Burnstock G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1100-4. PubMed ID: 8263771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction.
    Tsentsevitsky A; Kovyazina I; Nikolsky E; Bukharaeva E; Giniatullin R
    Neuroscience; 2013 Sep; 248():699-707. PubMed ID: 23806718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous purines modulate K
    Guarracino JF; Cinalli AR; Veggetti MI; Losavio AS
    J Neurosci Res; 2018 Jun; 96(6):1066-1079. PubMed ID: 29436006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 receptors modulate high voltage-activated Ca2+ currents and motor pattern generation in the xenopus embryo.
    Brown P; Dale N
    J Physiol; 2000 Jun; 525 Pt 3(Pt 3):655-67. PubMed ID: 10856119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intrinsic modulation of synaptic transmission by ATP in mouse fast twitch muscle.
    Hong SJ; Chang CC
    J Neurophysiol; 1998 Nov; 80(5):2550-8. PubMed ID: 9819262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine inhibits L-type Ca2+ current and catecholamine release in the rabbit carotid body chemoreceptor cells.
    Rocher A; Gonzalez C; Almaraz L
    Eur J Neurosci; 1999 Feb; 11(2):673-81. PubMed ID: 10051768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A₁ and A₂A receptor-mediated modulation of acetylcholine release in the mice neuromuscular junction.
    Garcia N; Priego M; Obis T; Santafe MM; Tomàs M; Besalduch N; Lanuza MA; Tomàs J
    Eur J Neurosci; 2013 Jul; 38(2):2229-41. PubMed ID: 23607735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 adenosine receptors modulate respiratory activity of the neonatal mouse via the cAMP-mediated signaling pathway.
    Mironov SL; Langohr K; Richter DW
    J Neurophysiol; 1999 Jan; 81(1):247-55. PubMed ID: 9914285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.
    Silinsky EM
    J Physiol; 2004 Jul; 558(Pt 2):389-401. PubMed ID: 15146054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1989 Jan; 96(1):211-9. PubMed ID: 2924073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of suramin upon ecto-apyrase activity and synaptic depression of Torpedo electric organ.
    Martí E; Cantí C; Gómez de Aranda I; Miralles F; Solsona C
    Br J Pharmacol; 1996 Jul; 118(5):1232-6. PubMed ID: 8818348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of neuromuscular effects of adenosine by specific adenosine A1-receptor antagonist in live rats.
    Nitahara K; Vizi ES; Shono S; Iihoshi M; Higuchi H; Higa K
    Int J Neurosci; 2005 Mar; 115(3):405-10. PubMed ID: 15804723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of A1-adenosine receptor antagonists on purinergic transmission in the guinea-pig vas deferens in vitro.
    Hardy TA; Brock JA
    Br J Pharmacol; 1999 Apr; 126(8):1761-8. PubMed ID: 10372818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine drives recycled vesicles to a slow-release pool at the mouse neuromuscular junction.
    Perissinotti PP; Uchitel OD
    Eur J Neurosci; 2010 Sep; 32(6):985-96. PubMed ID: 20726887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic inhibition of spontaneous acetylcholine release induced by adenosine at the mouse neuromuscular junction.
    De Lorenzo S; Veggetti M; Muchnik S; Losavio A
    Br J Pharmacol; 2004 May; 142(1):113-24. PubMed ID: 15066904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint.
    Dowd E; McQueen DS; Chessell IP; Humphrey PP
    Br J Pharmacol; 1998 Nov; 125(6):1267-71. PubMed ID: 9863656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.